Persistence of Bactericidal Activity at 4 Years After 2 Primary Doses of a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Booster Dose in Ad...

por Nolan, Terry, Garfield, Hartley, Gupta, Anil, Ferguson, Murdo, Marshall, Helen, D’Agostino, Diego, Toneatto, Daniela
Publicado 2017

1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants

por Scheifele, David W., Ferguson, Murdo, Predy, Gerald, Dawar, Meena, Assudani, Deepak, Kuriyakose, Sherine, Van Der Meeren, Olivier, Han, Htay Htay
Publicado 2014

Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a...

por Galgani, Ilaria, Annaratone, Margherita, Casula, Daniela, Di Maro, Gennaro, Janssens, Michel, Tasciotti, Annaelisa, Schwarz, Tino, Ferguson, Murdo, Arora, Ashwani Kumar
Publicado 2022

Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

por Madan, Anuradha, Segall, Nathan, Ferguson, Murdo, Frenette, Louise, Kroll, Robin, Friel, Damien, Soni, Jyoti, Li, Ping, Innis, Bruce L., Schuind, Anne
Publicado 2016

Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: Results from a randomized study

por Romanowski, Barbara, Schwarz, Tino F, Ferguson, Linda M, Ferguson, Murdo, Peters, Klaus, Dionne, Marc, Schulze, Karin, Ramjattan, Brian, Hillemanns, Peter, Behre, Ulrich, Suryakiran, Pemmaraju, Thomas, Florence, Struyf, Frank
Publicado 2014

152. Protective Antibody Levels 7.5 Years After Primary Vaccination in Adolescence With a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine (4CMenB) and Response to a Boo...

por Nolan, Terry, O’Ryan, Miguel, Santolaya, María Elena, De Looze, Ferdinandus, Marshall, Helen, Richmond, Peter, Henein, Sam, Rheault, Paul, Heaton, Ken, Perrett, Kirsten, Garfield, Hartley, Gupta, Anil, Ferguson, Murdo, D’Agostino, Diego, Toneatto, Daniela
Publicado 2018

Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus

por Van Der Meeren, Olivier, Peterson, James T., Dionne, Marc, Beasley, Richard, Ebeling, Peter R., Ferguson, Murdo, Nissen, Michael D., Rheault, Paul, Simpson, Richard W., De Ridder, Marc, Crasta, Priya D., Miller, Jacqueline M., Trofa, Andrew F.
Publicado 2016

Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine

por Folschweiller, Nicolas, Behre, Ulrich, Dionne, Marc, Durando, Paolo, Esposito, Susanna, Ferguson, Linda, Ferguson, Murdo, Hillemanns, Peter, McNeil, Shelly A, Peters, Klaus, Ramjattan, Brian, Schwarz, Tino F, Supparatpinyo, Khuanchai, Suryakirian, Pemmaraju V, Janssens, Michel, Moris, Philippe, Decreux, Annabelle, Poncelet, Sylviane, Struyf, Frank
Publicado 2019

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 an...

por Boutry, Céline, Hastie, Andrew, Diez-Domingo, Javier, Tinoco, Juan Carlos, Yu, Chong-Jen, Andrews, Charles, Beytout, Jean, Caso, Covadonga, Cheng, Huey-Shinn, Cheong, Hee Jin, Choo, Eun Ju, Curiac, Dan, Di Paolo, Emmanuel, Dionne, Marc, Eckermann, Tamara, Esen, Meral, Ferguson, Murdo, Ghesquiere, Wayne, Hwang, Shinn-Jang, Avelino-Silva, Thiago Junqueira, Kosina, Pavel, Liu, Chiu-Shong, Markkula, Jukka, Moeckesch, Beate, Murta de Oliveira, Cláudia, Park, Dae Won, Pauksens, Karlis, Pirrotta, Paola, Plassmann, Georg, Pretswell, Carol, Rombo, Lars, Salaun, Bruno, Sanmartin Berglund, Johan, Schenkenberger, Isabelle, Schwarz, Tino, Shi, Meng, Ukkonen, Benita, Zahaf, Toufik, Zerbini, Cristiano, Schuind, Anne, Cunningham, Anthony L
Publicado 2021